Procedural Sedation and Analgesia for Treatment of Adults With Fractures and Dislocations in the Emergency Department (PAINEX)

December 17, 2025 updated by: Sophie Sværke, Region Zealand

The goal of this observational study is to evaluate the effectiveness and safety of different procedural sedation and analgesia methods used for adults with painful fractures requiring reduction treatment in the emergency department.

The main questions it aims to answer are:

  • Which sedation and analgesia methods provide the best patient satisfaction and pain relief?
  • How do different treatment methods affect clinician satisfaction and the occurrence of adverse events?

The investigators will compare different types of procedural sedative and analgesic treatments (such as systemic sedation/analgesia and regional techniques like nerve or hematoma blocks) to see which approach offers the best patient satisfaction and most effective pain control.

Participants will:

Be adult patients with upper or lower extremity fractures or joint dislocations requiring painful reduction procedures.

Receive one of the routinely used sedation or analgesia treatments (or no analgesia) during their emergency department care.

Report their pain levels and satisfaction before, during, and after treatment. Be monitored for any side effects, complications, or use of antidotes. Data will be collected over a six-month period at Odense University Hospital, Holbæk Hospital, and Zealand University Hospital, Køge, following the STROBE guidelines for observational studies.

Study Overview

Detailed Description

Please refer to the full protocol.

Study Type

Observational

Enrollment (Estimated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Region Sjælland
      • Holbæk, Region Sjælland, Denmark, 4600
        • Recruiting
        • Emergency Department, Holbæk Hospital
        • Contact:
        • Principal Investigator:
          • Martin Schou, MD
        • Sub-Investigator:
          • Anders Krusenstjerna-Hafstrøm, MD
      • Køge, Region Sjælland, Denmark, 4600
        • Recruiting
        • Emergency Department, Zealand University Hospital
        • Contact:
        • Principal Investigator:
          • Marie-Laure Bouchy Jacobsson, MD
    • Region Syddanmark
      • Odense, Region Syddanmark, Denmark, 5000
        • Recruiting
        • Emergency Department, Odense University Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Eligible patients with upper and lower extremity injuries that require painful stabilizing treatment in the emergency department.

Description

Inclusion Criteria:

  1. Age ≥18.
  2. Patients with the following injuries are eligible:

    1. Reduction treatment of shoulder dislocation
    2. Reduction treatment of elbow dislocation
    3. Reduction treatment of distal radius fractures, application of cast
    4. Reduction treatment of finger fractures/dislocation
    5. Casting treatment of upper extremity fractures

      • Proximal humerus fracture, application of fixed sling
      • Humeral shaft fracture, application of Sarmiento brace
      • Supracondylar fracture, application of angled cast
    6. Reduction treatment of hip dislocation
    7. Reduction treatment of patella dislocation
    8. Reduction of tibial shaft fracture, application of cast
    9. Reduction treatment of ankle fractures including distal tibia fracture
    10. Reduction treatment for toe fractures/dislocation
    11. Casting treatment of lower extremity fractures

      • Distal femur fracture, application of cast/traction
      • Proximal tibia fracture, application of cast or hinged brace
      • Ankle fracture, application of walker

Exclusion Criteria:

  1. Unable to give informed consent (e.g. unconscious, psychotic or dementia)
  2. Unwilling to participate in the study
  3. Prior inclusion in the study
  4. Already included in another clinical study at the same day/hospital visit
  5. Pregnant or breastfeeding

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Extremity injuries
Each department will collect data on the treatment patients with the upper and lower extremity injuries receive during reduction or stabilizing treatment (procedural sedation and/or analgesia, or no treatment).
No intervention: Patients will receive usual care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient satisfaction via Numerical Rating Scale
Time Frame: Immediately after the procedure

Patient satisfaction with the procedural sedation regimen will be assessed using the 11-point Numerical Rating Scale, which ranges from 0 to 10, where 0 indicates complete dissatisfaction and 10 indicates complete satisfaction. Higher scores will reflect a better outcome.

Patients will be assessed clinically for alertness and readiness to respond before being asked the outcome questions. Only once they are awake and able to provide informed responses will the assessments be performed.

Immediately after the procedure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Re-call of maximum pain intensity
Time Frame: Immediately after the procedure

Re-call of the maximum pain intensity during the treatment procedure will be assessed using the Numerical Rating Scale, which ranges from 0 to 10, where 0 indicates no pain and 10 indicates the worst pain imaginable. Higher scores will reflect a worse outcome.

Patients will be assessed clinically for alertness and readiness to respond before being asked the outcome questions. Only once they are awake and able to provide informed responses will the assessments be performed.

Immediately after the procedure
Patient satisfaction via Short Assessment of Patient Satisfaction
Time Frame: Immediately after the procedure

Patient satisfaction with the sedation regimen and treatment will be assessed using the Short Assessment of Patient Satisfaction, which consists of 7 items, each scored from 0 to 4, yielding a total score ranging from 0 to 28, with the overall score reflecting a continuum from very dissatisfied to very satisfied. Higher scores will indicate greater patient satisfaction.

Patients will be assessed clinically for alertness and readiness to respond before being asked the outcome questions. Only once they are awake and able to provide informed responses will the assessments be performed.

Immediately after the procedure
Clinician satisfaction with analgosedation regimen
Time Frame: Immediately after the procedure

Clinician satisfaction with the analgosedation regimen will be assessed using the Numerical Rating Scale, which ranges from 0 to 10, where 0 indicates complete dissatisfaction and 10 indicates complete satisfaction. Higher scores will reflect a better outcome.

Patients will be assessed clinically for alertness and readiness to respond before being asked the outcome questions. Only once they are awake and able to provide informed responses will the assessments be performed.

Immediately after the procedure
Incidence of adverse events
Time Frame: During and immediately after the procedure

Incidence of the following adverse events will be recorded: hypoxia, hypotension, treatment-requiring bradycardia, nausea, vomiting, hallucinations, and the need for reversal agents (antidote medication). Each event will be reported as a dichotomous outcome (present or absent).

Patients will be assessed clinically for alertness and readiness to respond before being asked the outcome questions. Only once they are awake and able to provide informed responses will the assessments be performed.

During and immediately after the procedure

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient satisfaction via 5-point Likert Scale
Time Frame: Immediately after the procedure

Patient satisfaction with the sedation regimen and treatment will be assessed using a 5-point Likert Scale, which ranges from 1 to 5, where 1 indicates very dissatisfied and 5 indicates very satisfied. Higher scores will reflect a better outcome.

Patients will be assessed clinically for alertness and readiness to respond before being asked the outcome questions. Only once they are awake and able to provide informed responses will the assessments be performed.

Immediately after the procedure
Incidence of procedural amnesia
Time Frame: Immediately after the procedure

Incidence of procedural amnesia will be assessed as a patient-reported outcome. Each case will be recorded as present or absent. Higher incidence reflects a better outcome.

Patients will be assessed clinically for alertness and readiness to respond before being asked the outcome questions. Only once they are awake and able to provide informed responses will the assessments be performed.

Immediately after the procedure
Incidence of dissociative experience during treatment
Time Frame: Immediately after the procedure

Incidence of dissociative experience during the treatment procedure will be assessed as a patient- and physician-reported outcome. Each case will be recorded as present or absent and categorized as a good or bad experience. A higher incidence of bad experiences will reflect a worse outcome, whereas a higher incidence of good experiences will reflect a better outcome.

Patients will be assessed clinically for alertness and readiness to respond before being asked the outcome questions. Only once they are awake and able to provide informed responses will the assessments be performed.

Immediately after the procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 29, 2025

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

July 1, 2026

Study Registration Dates

First Submitted

December 5, 2025

First Submitted That Met QC Criteria

December 17, 2025

First Posted (Estimated)

January 2, 2026

Study Record Updates

Last Update Posted (Estimated)

January 2, 2026

Last Update Submitted That Met QC Criteria

December 17, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Analgesia

Clinical Trials on Usual Care

Subscribe